These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3692613)

  • 1. Clinical course of an exacerbated pulmonary infection in a girl with cystic fibrosis (CF).
    Dockter G
    Infection; 1987; 15(5):378-80. PubMed ID: 3692613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis.
    Rosenstein BJ; Hall DE
    Johns Hopkins Med J; 1980 Nov; 147(5):188-9. PubMed ID: 7441939
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
    Kerrebijn KF; Mouton J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):28-33. PubMed ID: 2130712
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of inflammatory response, infection, and pulmonary function in cystic fibrosis.
    Pereira LC; Moreira EA; Bennemann GD; Moreno YM; Buss Zda S; Barbosa E; Ludwig-Neto N; Wilhelm Filho D; Fröde TS
    Life Sci; 2014 Jul; 109(1):30-6. PubMed ID: 24931908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study].
    da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J
    Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection, inflammation, and lung function decline in infants with cystic fibrosis.
    Pillarisetti N; Williamson E; Linnane B; Skoric B; Robertson CF; Robinson P; Massie J; Hall GL; Sly P; Stick S; Ranganathan S;
    Am J Respir Crit Care Med; 2011 Jul; 184(1):75-81. PubMed ID: 21493738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.
    Döring G; Conway SP; Heijerman HG; Hodson ME; Høiby N; Smyth A; Touw DJ
    Eur Respir J; 2000 Oct; 16(4):749-67. PubMed ID: 11106223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The difficulties of treating infection in adults with cystic fibrosis.
    Webb AK
    Monaldi Arch Chest Dis; 1993 Dec; 48(6):657-61. PubMed ID: 8124307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.
    Kerem E; Viviani L; Zolin A; MacNeill S; Hatziagorou E; Ellemunter H; Drevinek P; Gulmans V; Krivec U; Olesen H;
    Eur Respir J; 2014 Jan; 43(1):125-33. PubMed ID: 23598952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pseudomonas infections in lungs of children born with cystic fibrosis. Effects and adverse effects during antibiotic therapy with tobramycin and carbenicillin].
    Friis B; Thomsen J
    Ugeskr Laeger; 1979 Jul; 141(29):1968-72. PubMed ID: 545764
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Greally P; Whitaker P; Peckham D
    Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
    Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
    JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of bacterial bronchitis in cystic fibrosis.
    Smith A
    Pediatr Infect Dis J; 1997 Jan; 16(1):91-5; discussion 95-6, 123-6. PubMed ID: 9002117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas cepacia-associated pneumonia in cystic fibrosis. Relation of clinical features to histopathologic patterns of pneumonia.
    Tomashefski JF; Thomassen MJ; Bruce MC; Goldberg HI; Konstan MW; Stern RC
    Arch Pathol Lab Med; 1988 Feb; 112(2):166-72. PubMed ID: 3337628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.
    Church DA; Kanga JF; Kuhn RJ; Rubio TT; Spohn WA; Stevens JC; Painter BG; Thurberg BE; Haverstock DC; Perroncel RY; Echols RM
    Pediatr Infect Dis J; 1997 Jan; 16(1):97-105; discussion 123-6. PubMed ID: 9002118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy.
    Levy J
    Chest; 1988 Aug; 94(2 Suppl):150S-156S. PubMed ID: 3135160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas colonization in cystic fibrosis. A study of 160 patients.
    Kulczycki LL; Murphy TM; Bellanti JA
    JAMA; 1978 Jul; 240(1):30-4. PubMed ID: 96277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Pseudomonas aeruginosa infection and respiratory muscle impairment in cystic fibrosis.
    Dassios TG; Katelari A; Doudounakis S; Dimitriou G
    Respir Care; 2014 Mar; 59(3):363-70. PubMed ID: 23983273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunohistological evaluation of Pseudomonas aeruginosa pulmonary infection in two patients with cystic fibrosis.
    Speert DP; Dimmick JE; Pier GB; Saunders JM; Hancock RE; Kelly N
    Pediatr Res; 1987 Dec; 22(6):743-7. PubMed ID: 3431961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.